Literature DB >> 21191721

Development of anisometropia in patients after surgery for esotropia.

Takashi Fujikado1, Takeshi Morimoto, Hiroshi Shimojyo.   

Abstract

PURPOSE: Anisometropia is reported to increase with age; however, the relationship between the development of anisometropia and binocular vision has not been determined. The purpose of this study was to determine the relationship between anisometropia and binocular vision after esotropia (ET) surgery.
METHODS: The medical records of 51 consecutive patients with ET who had undergone ET surgery were studied. Patients with amblyopia or anisometropia ≥2 diopters (D) before surgery were excluded. The average age of the patients at the time of surgery was 4.5 ± 3.7 years, and the average postoperative period was 5.0 ± 2.2 years. The refractive errors (spherical equivalent) in both eyes were measured preoperatively and postoperatively. Binocular visual function was evaluated with a modified Worth-4 dot test.
RESULTS: At the final visit, average anisometropia was 0.98 ± 1.30 D, which was significantly greater than the preoperative value of 0.36 ± 0.46 D (P < 0.001). Anisometropia ≥2 D was observed in ten patients (23%) postoperatively. One patient was able to fuse a target of ≥2° (10%) in the anisometropia ≥2 D group, significantly fewer than the 13 patients (32%) in the anisometropia <2.0 D group (P = 0.02).
CONCLUSIONS: Anisometropia may develop in patients with poor sensory fusion after surgery for esotropia.

Entities:  

Mesh:

Year:  2010        PMID: 21191721     DOI: 10.1007/s10384-010-0868-z

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  9 in total

1.  Association of ocular dominance and anisometropic myopia.

Authors:  Ching-Yu Cheng; May-Yung Yen; Hsin-Yi Lin; Wei-Wei Hsia; Wen-Ming Hsu
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

2.  Prevalence of anisometropia in Taiwanese schoolchildren.

Authors:  Yung-Feng Shih; Chu Hsing Kate Hsiao; Shu-Hui Wen; Luke Long-Kuang Lin; Chien-Jen Chen; Por-Tying Hung
Journal:  J Formos Med Assoc       Date:  2005-06       Impact factor: 3.282

3.  Long-term motor and sensory outcomes after early surgery for infantile esotropia.

Authors:  Eileen E Birch; David R Stager
Journal:  J AAPOS       Date:  2006-10       Impact factor: 1.220

4.  Prevalence of habitual refractive errors and anisometropia among Dutch schoolchildren and hospital employees.

Authors:  Theo J W Hendricks; John de Brabander; Marlou H P Vankan-Hendricks; Frans G van der Horst; Fred Hendrikse; J Andre Knottnerus
Journal:  Acta Ophthalmol       Date:  2009-03-27       Impact factor: 3.761

5.  Final report of the early vs. late infantile strabismus surgery study (ELISSS), a controlled, prospective, multicenter study.

Authors:  H J Simonsz; G H Kolling; K Unnebrink
Journal:  Strabismus       Date:  2005-12

Review 6.  Success of monovision in presbyopes: review of the literature and potential applications to refractive surgery.

Authors:  S Jain; I Arora; D T Azar
Journal:  Surv Ophthalmol       Date:  1996 May-Jun       Impact factor: 6.048

7.  Anisometropia is independently associated with both spherical and cylindrical ametropia.

Authors:  Xue-Jiao Qin; Tom H Margrain; Chi Ho To; Nathan Bromham; Jeremy A Guggenheim
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

Review 8.  Retinal-image mediated ocular growth as a mechanism for juvenile onset myopia and for emmetropization. A literature review.

Authors:  D A Goss; M G Wickham
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

9.  Anisometropia and binocularity.

Authors:  S E Brooks; D Johnson; N Fischer
Journal:  Ophthalmology       Date:  1996-07       Impact factor: 12.079

  9 in total
  1 in total

1.  Correlation between myopic ametropia and stereoacuity in school-aged children in Taiwan.

Authors:  Ju-Wen Yang; Tien-Yi Huang; Jiahn-Shing Lee; Ling Yeung; Yi-Fang Lin; Chi-Chin Sun
Journal:  Jpn J Ophthalmol       Date:  2013-02-05       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.